H.R. 8528 is a bill proposed to amend the Social Security Act, specifically title XVIII, with the aim of improving access to skilled nursing facilities for patients with primary immunodeficiency. This likely involves changes to Medicare coverage or regulations to ensure that individuals with primary immunodeficiency have better or more affordable access to necessary care in skilled nursing facilities.
Supporters of H.R. 8528 argue that the bill addresses a critical gap in healthcare access for patients with primary immunodeficiency. By potentially expanding Medicare coverage, the bill could ensure that these vulnerable patients receive the specialized care they need without facing financial hardship. Proponents emphasize the importance of timely and adequate care for improving health outcomes and quality of life for these individuals.
Critics of H.R. 8528 may express concerns about the potential increase in healthcare costs associated with expanding access to skilled nursing facilities. Some may argue that the bill could lead to increased Medicare spending, which might necessitate budget adjustments or cuts to other programs. There might also be skepticism about whether the bill adequately addresses all barriers to access for primary immunodeficiency patients or if it primarily benefits certain healthcare providers.
Based on the available data, there appears to be a low risk of conflict of interest between Representative Adrian Smith's campaign donors and the subject matter of H.R. 8528. No direct industry overlaps were detected between the bill's subject matter and the sponsor's top donor industries, which suggests that the bill's provisions are not likely to directly benefit the sponsor's financial supporters. However, it is worth noting that there has been significant lobbying activity in the bill's policy area. The highest lobbying expenditure came from BAE, Kim & Lee, LLC, which spent $370,000 via The McKeon Group, Inc. The exact nature of this lobbying activity is not specified, but it does indicate that there are interests invested in the policy area of this bill. The total lobbying expenditure in this bill's policy area is $626,000.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| BAE, KIM & LEE, LLC | THE MCKEON GROUP, INC. | $370,000 |
| MBK PARTNERS | THE MCKEON GROUP, INC. | $150,000 |
| B. BRAUN MEDICAL INC. | POLSINELLI PC | $70,000 |
| VECTOR | THE MCKEON GROUP, INC. | $40,000 |
| SOLUTION PHILIPPINES, LLC | THE MCKEON GROUP, INC. | $40,000 |
| AMERICAN PHARMACISTS ASSOCIATION | AMERICAN PHARMACISTS ASSOCIATION | $35,000 |
| TRAVERE THERAPEUTICS | THE HEALTH EQUITY STRATEGIES GROUP, LLC | $16,000 |
| D-WAVE GOVERNMENT, INC | THE MCKEON GROUP, INC. | $10,000 |
| NATIONAL ASSOCIATION OF RSVP PROGRAM DIRECTORS | THE SUSQUEHANNA GROUP | $5,000 |
| ROWAN UNIVERSITY | ROWAN UNIVERSITY | undisclosed |
| STR8 CORPORATION | BRODY GROUP L.L.C. PUBLIC AFFAIRS | undisclosed |
| WEST GULF MARITIME ASSOCIATION | WEST GULF MARITIME ASSOCIATION | undisclosed |
| CENTRAL ADMIXTURE PHARMACY SERVICES, INC. | POLSINELLI PC | undisclosed |
| CARTRIDGE TECHNOLOGIES, LLC | CHECKMATE GOVERNMENT RELATIONS | undisclosed |
| BLUE DIAMOND ATOMICS | NATURAL STATE CONSULTING AND STRATEGIES | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Adrian Smith, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
